Myriad Genetics (MYGN) PT Raised to $30 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Dan Brennan raised the price target on Myriad Genetics (NASDAQ: MYGN) to $30.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
